<DOC>
	<DOCNO>NCT02604576</DOCNO>
	<brief_summary>Multi-center , randomize , superiority , double blind clinical trial ass efficacy fixed-dose combination bromopride simethicone versus isolate bromopride research participant diagnose functional dyspepsia .</brief_summary>
	<brief_title>Efficacy Bromopride Simethicone Versus Bromopride Functional Dyspepsia</brief_title>
	<detailed_description>Multi-center , randomize , superiority , double blind clinical trial ass efficacy fixed-dose combination bromopride simethicone versus isolate bromopride relief os dyspepsia symptom research participant diagnose functional dyspepsia .</detailed_description>
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Simethicone</mesh_term>
	<mesh_term>Bromopride</mesh_term>
	<mesh_term>Metoclopramide</mesh_term>
	<criteria>Signed Informed Consent ; Participants age 18 70 year ; Clinical diagnosis functional dyspepsia accord Rome III criterion ; Minimum score 22 point PADYQ questionnaire Diagnosis gastroesophageal reflux disease , irritable bowel syndrome , inflammatory bowel disease , gallstone , strongyloidiasis , giardiasis ascariasis , clinical disease significant psychological ; Positive diagnosis Helicobacter pylorus ; Clinically significant organic disease HDE ( High Digestive Endoscopy ) prior randomization ; History esophageal surgery , gastrointestinal intraabdominal surgery ; Hypersensitivity component formulation ; Allergy tartrazine yellow dye ; Allergy aspirin ; Use PPIs , H2 blocker , prokinetics , antibiotic , prostaglandin bismuth salt last week screen visit ; Use NSAIDs aspirin two day week ( except AAS &lt; 325mg / day ) , drug induce gastrointestinal symptom ; Pregnant woman woman without adequate contraception ; Advance Participation clinical trial protocol last twelve ( 12 ) month ( CNS Resolution 251 August 7 , 1997 , Part III , subsection J ) , unless investigator considers may direct benefit ; Changes hematological biochemical test : hemoglobin le 12 g / dl , result value 2 time reference AST , ALT , Gamma GT alkaline phosphatase ; Diagnosis neurological psychiatric disease decompensated diabetes ; Use drug anticholinergic action , narcotic analgesic , sedative , hypnotic tranquilizer ; Alcoholism sporadic use alcohol illicit drug use .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>functional dyspepsia</keyword>
</DOC>